Fenugreek
Fenugreek, licence 80090592: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Milkflow Booster, More Milk Plus, Vorst Fenugreek, Vorst Milkflow Booster, Vorst More Milk Plus
- Licence holder
- Celex Laboratories Inc.
- NPN or DIN-HM
- 80090592
- Status
- Active licence
- Licence date
- 13 February 2019
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine | 500.0 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Source : Foeniculum vulgare subsp. vulgare var. vulgare - Seed Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 60 mg | 3.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Fenugreek is (Traditionally) used in Herbal Medicine as a galactogogue/lactogogue to help promote milk production/secretion. Fenugreek is (Traditionally) used in Herbal Medicine as supportive therapy for the promotion of healthy glucose levels. Fenugreek is Used in Herbal Medicine to help reduce elevated blood lipid levels (hyperlipidemia). Fenugreek is Used in Herbal Medicine to help stimulate the appetite, as a digestive tonic to aid digestion, to help relieve dyspepsia and gastritis, and as a mild laxative. Fenugreek is Traditionally used in Herbal Medicine as an expectorant to help relieve excess mucous of the upper respiratory passages (anti-catarrhal).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician if you are pregnant or have diabetes. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are pregnant or breastfeeding.
- Effets indésirables connus
Stop use if hypersensitivity/allergy occurs.
Source
Official Health Canada record, licence 80090592
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.